The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prostate cancer incidence in hypogonadal men on long-term treatment with testosterone undecanoate injections.
Ahmad Haider
Honoraria - Bayer Schering Pharma
Research Funding - Bayer Schering Pharma
Other Remuneration - Bayer Schering Pharma; Takeda
Michael Zitzmann
Honoraria - Bayer Schering Pharma; Besins Healthcare; Ferring
Research Funding - Bayer Schering Pharma
Other Remuneration - Bayer Schering Pharma; Lilly
Aksam Yassin
Honoraria - Bayer Schering Pharma
Research Funding - Bayer Schering Pharma
Other Remuneration - Bayer Schering Pharma; Teva